CD46 induction of the Tr1 phenotype is dysregulated in MS and other chronic inflammatory diseases, as CD46-costimulated T cells in these patients secrete less IL-10 but normal levels of IFN-γ (14, 16, 18–21). Here, CD46 is linked to myeloid sarcoma.